Edesa Biotech Inc (EDSA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.55
• Market Cap: $11.35M
• EPS: $-1.07
• 52-Week High: $2.95
• 52-Week Low: $0.72

Market Sentiment

Edesa Biotech Inc currently has a Bullish sentiment score of 0.79.

About Edesa Biotech Inc

Edesa Biotech Inc. (EDSA), a clinical-stage biopharmaceutical company based in Markham, Canada, is dedicated to developing innovative therapies targeting inflammatory and immune-related diseases. With a strong focus on unmet medical needs, Edesa's pipeline features proprietary technologies aimed at advancing treatment options for dermatological and gastrointestinal disorders. As the company progresses through its clinical trials, it is poised to establish a significant presence in the biother...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Edesa Biotech Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EDSA pay dividends?

Edesa Biotech Inc (EDSA) does not currently pay a regular dividend.

What is EDSA's market cap?

Edesa Biotech Inc (EDSA) has a market capitalization of $11.35M with a current stock price of $1.55.